文献速递心血管PETCT

心肌血流量与炎症性心脏结节病

Myocardial Blood Flow and Inflammatory Cardiac Sarcoidosis.
PubMed 文献 · JACC Cardiovasc Imaging · 2017-01-18

研究评估炎症性结节病对冠状动脉循环功能及免疫抑制治疗反应的影响。32例疑诊或确诊心脏结节病患者行18F-氟脱氧葡萄糖和13N-氨正电子发射断层摄影/计算机断层摄影,25例次表现为灌注正常但有区域炎症,21例次表现为区域灌注缺损伴炎症。炎症心肌的高充血心肌血流量显著低于远程区域;免疫抑制后炎症减轻与随访时心肌血流储备保留相关,而炎症无变化或增加区域的MFR显著恶化。

要点

  • 炎症心肌在高充血状态下心肌血流量显著低于远程心肌。
  • 免疫抑制治疗后炎症减轻与随访时心肌血流储备保留相关。
  • 炎症无变化或增加的区域随访时心肌血流储备显著恶化。

核心结论

  • 结节病介导的心肌炎症与冠状动脉循环功能的区域 impairment 相关;免疫抑制治疗相关的炎症变化与冠状动脉血管扩张能力变化之间的关联提示炎症对心脏结节病冠状动脉循环功能有直接不良影响。

研究设计与样本

  • 研究纳入32例因已知或疑似心脏结节病转诊行正电子发射断层摄影/计算机断层摄影的个体,采用18F-氟脱氧葡萄糖评估炎症、13N-氨评估灌注缺损,检查前高脂/低碳水化合物饮食并禁食>12小时以抑制心肌葡萄糖摄取;炎症以标准化摄取值量化,静息及瑞加德松刺激高充血状态下的区域心肌血流量以ml/g/min测定;18例在中位随访2.5年(四分位距1.3至3.4年)后重复正电子发射断层摄影。

诊断标准与关键数值

  • 25例次检查灌注正常但有区域炎症证据(第1组),21例次检查表现为区域灌注缺损伴炎症(第2组)。
  • 第1组炎症心肌与非炎症心肌的中位心肌血流量分别为0.86 ml/g/min(IQR 0.66至1.11 ml/g/min)与0.83 ml/g/min(IQR 0.64至1.12 ml/g/min)。
  • 第2组炎症心肌与非炎症心肌的中位心肌血流量分别为0.74 ml/g/min(IQR 0.60至0.93 ml/g/min)与0.77 ml/g/min(IQR 0.59至0.95 ml/g/min)。
  • 第1组炎症区域与远程区域的中位高充血心肌血流量分别为2.31 ml/g/min(IQR 1.81至2.95 ml/g/min)与2.70 ml/g/min(IQR 2.07至3.30 ml/g/min),p<0.001。
  • 第2组炎症区域与远程区域的中位高充血心肌血流量分别为1.61 ml/g/min(IQR 1.17至2.18 ml/g/min)与1.94 ml/g/min(IQR 1.49至2.39 ml/g/min),p<0.001。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: This study sought to evaluate the effects of inflammatory sarcoid disease on coronary circulatory function and the response to immune-suppressive treatment.

BACKGROUND: Although positron emission tomography assessment of myocardial inflammation is increasingly applied to identify active cardiac sarcoidosis, its effect on coronary flow and immune-suppressive treatment remains to be characterized.

METHODS: Thirty-two individuals, who were referred for positron emission tomography/computed tomography, were evaluated for known or suspected cardiac sarcoidosis applying 18F-fluorodeoxyglucose to determine inflammation and 13N-ammonia to assess for perfusion deficits following a high-fat/low-carbohydrate diet and fasting state >12 h to suppress myocardial glucose uptake. Inflammation was quantified with standardized uptake value and regional myocardial blood flow at rest and during regadenoson-stimulated hyperemia was determined in ml/g/min. Positron emission tomography studies were repeated in 18 cases with a median follow-up of 2.5 years (interquartile range [IQR]:1.3 to 3.4 years).

RESULTS: Twenty-five exams had normal perfusion but evidence of regional inflammation (group 1), and 21 exams presented a regional perfusion deficit associated with inflammation (group 2). Median myocardial blood flow did not differ between inflamed and noninflamed myocardium in both groups (0.86 ml/g/min [IQR: 0.66 to 1.11 ml/g/min] vs. 0.83 ml/g/min [IQR: 0.64 to 1.12 ml/g/min] and 0.74 ml/g/min [IQR: 0.60 to 0.93 ml/g/min] vs. 0.77 ml/g/min [IQR: 0.59 to 0.95 ml/g/min], respectively). As regards median hyperemic myocardial blood flows, they were significantly lower in the inflamed than in the remote regions in group 1 and 2 (2.31 ml/g/min [IQR: 1.81 to 2.95 ml/g/min] vs. 2.70 ml/g/min [IQR: 2.07 to 3.30 ml/g/min] and 1.61 ml/g/min [IQR: 1.17 to 2.18 ml/g/min] vs. 1.94 ml/g/min [IQR: 1.49 to 2.39 ml/g/min]; p < 0.001, respectively). Immune-suppression-mediated decrease in inflammation was associated with preserved myocardial flow reserve (MFR) at follow-up, whereas MFR significantly worsened in regions without changes or even increases in inflammation (median ΔMFR: 0.07 [IQR: -0.29 to 0.45] vs. -0.24 [IQR: -0.84 to 0.21]; p < 0.001). There was an inverse correlation between pronounced alterations in myocardial inflammation (Δ regional myocardial volume with standardized uptake value >4.1) and ΔMFR (r = -0.47; p = 0.048).

CONCLUSIONS: Sarcoid-mediated myocardial inflammation is associated with a regional impairment of coronary circulatory function. The association between immune-suppressive treatment-related alterations in myocardial inflammation and changes in coronary vasodilator capacity suggests direct adverse effect of inflammation on coronary circulatory function in cardiac sarcoidosis.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Kruse MJ, Kovell L, Kasper EK, et al. Myocardial Blood Flow and Inflammatory Cardiac Sarcoidosis. JACC Cardiovasc Imaging. 2017. PMID: 28109920. doi:10.1016/j.jcmg.2016.09.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。